agilon health, Inc. (NYSE:AGL) Q4 2022 Results Conference Call March 1, 2022 4:30 PM ET

Company Participants

Matthew Gillmor - VP, IR

Steve Sell - CEO

Tim Bensley - CFO

Conference Call Participants

Sandy Draper - Guggenheim

Whit Mayo - SVB Securities

Brian Tanquilut - Jefferies

David Larsen - BTIG

George Hill - Deutsche Bank

Jamie Perse - Goldman Sachs

Justin Lake - Wolfe Research

Kevin Fischbeck - Bank of America

Lisa Gill - JP Morgan

Ryan Daniels - William Blair

Sean Dodge - RBC

Stephen Baxter - Wells Fargo

Operator

Hello, everybody, and welcome to the agilon health Fourth Quarter 2022 earnings call. My name is Sam, and I'll be coordinating your call today. [Operator Instructions]

I will now hand you over to your host, Matthew Gillmor, Vice President of Investor Relations, to begin. Please go ahead.

Matthew Gillmor

Thank you, operator. Good afternoon, and welcome to the call. With me is our CEO, Steve Sell and our CFO, Tim Bensley. Following prepared remarks from Steve and Tim, we will conduct a Q&A session.

Before we begin, I'd like to remind you that our remarks and responses to questions may include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties with our business. These risks and uncertainties are discussed in our SEC filings. Please note that we assume no obligation to update any forward-looking statements.

Additionally, certain financial measures we will discuss on this call are non-GAAP financial measures. We believe that providing these measures helps investors gain a better and more complete understanding of our financial results and is consistent with how management views our financial results. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measure is available in the earnings press release and Form 8-K filed with the SEC.

And with that, I'll turn the call over to Steve.

Steve Sell

Thanks, Matt. Good evening, and thank you for joining us. 2022 was a very strong year for agilon and our physician partners, and we have entered 2023 with incredible momentum. We have made significant progress against our vision to transform health care in 100-plus communities by empowering primary care doctors to accelerate the transition to a value-based care system.

The research analysis we published in mid-January highlights the success of our model, specifically in patients with diabetes. As many of you know, diabetes affects about 30% of the Medicare population and if not properly managed, can have significant long-term health consequences for seniors.